Trademark Overview
On Monday, September 29, 2025, a trademark application was filed for DIRECT ACCESS PLATFORM with the United States Patent and Trademark Office. The USPTO has given the DIRECT ACCESS PLATFORM trademark a serial number of 99418600. The federal status of this trademark filing is REGISTERED as of Tuesday, July 7, 2026. This trademark is owned by CheckMySpot, Inc.. The DIRECT ACCESS PLATFORM trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Platform as a service (PAAS) services featuring computer software platforms for telemedicine services; Platform as a service (PAAS) services featuring computer software platforms for the prioritized referral of patients based on scheduling, treatment, and patient satisfaction metrics; Platform as a service (PAAS) services featuring computer software platforms for pairing patients and providers together to treat dermatological conditions in compliance with federal and state laws; Platform as a service (PAAS) services featuring computer software platforms for pairing patients and providers together based on geolocation to treat dermatological conditions in compliance with federal and state laws; Platform as a service (PAAS) services featuring computer software platforms for the treatment of dermatological conditions
Providing medical information to patients in the form of reports in the field of dermatological conditions; Telemedicine services; Telemedicine services for the treatment of dermatological conditions; telehealth services, being health care services provided online, for the treatment of dermatological conditions; Telemedicine services for the treatment of dermatological conditions performed using a platform design to pair patients and providers in compliance with federal and state laws; telehealth services, being health care services provided online using a platform design to pair patients and providers based on geolocation in compliance with federal and state laws, for the treatment of dermatological conditions; Telemedicine services for the treatment of dermatological conditions performed using a platform design to pair patients and providers by prioritizing providers based on scheduling, treatment, and patient satisfaction metrics
